AnalystBook Research · Company Intelligence

Surgery Partners, Inc.

SGRYNasdaq

Built from Surgery Partners, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Surgery Partners, Inc.: Revenue grew 6.2% to $3.309B from $3.114B. Net loss narrowed to $77.9M from $168M. Free cash flow declined 6.7% to $196M from $210M. Operating margin expanded 57 bps to 11.77%. Surgery Partners, Inc.'s annual comparison also shows free cash flow declined despite revenue growth; margins improved while free cash flow declined; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 6.2% to $3.309B from $3.114BOK
  • ProfitabilityNet loss narrowed to $77.9M from $168MOK
  • Cash flowFree cash flow declined 6.7% to $196M from $210MWatch
  • MarginsOperating margin expanded 57 bps to 11.77%OK
  • AccountingDistress-range screen needs contextWatch
  • Insiders0 purchases and 16 salesWatch

Business

We are dependent upon government and private insurance sources of payment for the services we provide.

Where the revenue comes from

Fiscal 2025, as Surgery Partners, Inc. reports it. History and quarterly detail are in the app.

  • Patient service revenues$3.2B
  • Other Services$82.4M

Leadership changes

From Surgery Partners, Inc.'s own filings, the day they're filed.

  • Harrison R. Bane · President · departureeff. 2025-10-03
  • Blair E. Hendrix · Chairman · departureeff. 2025-08-04
  • Laura L. Forese · directors · appointment

Latest filings

  • 8-K · Company announcement2026-08-10
  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-07-24
  • 8-K · Company announcement2026-06-05
  • 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Surgery Partners, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.